Showing results (1801-1810 of 1,881) with videos related to

Sort By:
Pageof 189
Immunotherapy|November 18, 2024
ctDNA-guided adjuvant immunotherapy in colorectal cancerNicholas Burley, Yurhee Lee, Louisa Liu, et al.
Immunotherapy|November 16, 2024
Fatal rhabdomyolysis and fulminant myocarditis with malignant arrhythmias after one dose of ipilimumab and nivolumabMarko Kurnik, Petra Kolar Kus, Mihela Krepek, et al.
Immunotherapy|August 9, 2024
The role of nemolizumab in the treatment of atopic dermatitis for the adult populationStuti Prajapati, Joseph P Flemming, Danyaal Khan, et al.
Immunotherapy|July 17, 2024
Tocilizumab and CytoSorb for delayed severe cytokine release syndrome after ipilimumab plus nivolumab immunotherapyMarko Kurnik, Fazarinc Peter, Podbregar Matej
Immunotherapy|July 25, 2024
Selection of allergen extract for immunotherapy in polysensitized allergic rhinitis patientsElizabeth García, Juan-Camilo Ardila, Nardey Crespo, et al.
Immunotherapy|July 25, 2024
Deterioration in multifocal motor neuropathy upon treatment of immune-related adverse events of checkpoint inhibitionVera Elisabeth Adreana Kleinveld, Julia Wanschitz, Wolfgang N Löscher, et al.
Immunotherapy|July 29, 2024
A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescentsMaria Fasshauer, Gesine Schuermann, Norbert Gebert, et al.
Immunotherapy|July 23, 2024
Failure of immune checkpoint inhibitors for microsatellite instability-positive pancreatic adenocarcinoma with atypical pattern of short tandem repeat mutationAnna Babayan, Evgeny Ledin, Alexandra Lebedeva, et al.
Immunotherapy|June 18, 2024
Paraneoplastic dermatomyositis and Stevens-Johnson syndrome related to immunotherapyKaterina Kampoli, Ioannis Tsamis, Dimitrios Sgouros, et al.
Immunotherapy|September 6, 2023
Tackling the immunotherapy conundrum: advances and challenges for operable non-small-cell lung cancer treatmentFouad Attieh, Antoine Chartouni, Marc Boutros, et al.
Pageof 189